臻鐳科技(688270.SH):2024年度公司產品綜合毛利率有所下降
格隆匯2月18日丨臻鐳科技(688270.SH)近日在接待機構投資者調研時表示,2024年度公司產品綜合毛利率有所下降,主要受產品結構及其出貨量的變化所致。公司產品價格一直以來實行階梯報價,採購數量越多,價格相對越實惠,2024年度公司微系統及模組產品出貨量及應用規模擴大,疊加微系統及模組產品穩態毛利率顯著低於公司芯片類產品,由此導致公司2024年度綜合毛利率有所下降。未來隨着微系統及模組產品規模量級的項目進入批產階段,或者行業競爭加劇,導致公司產品議價能力下降、成本費用提高,公司產品綜合毛利率仍將出現波動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.